NCT02614716 - A Study of LY3090106 in Participants With Sjögren's Syndrome (SS) | Biotech Hunter

Enrollment

32

Participants

Timeline

Start Date

December 10, 2015

Primary Completion Date

September 5, 2018

Study Completion Date

September 5, 2018

Conditions

Sjögren's Syndrome

Interventions

DRUG

LY3090106

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (7)

1612

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Sofia

16635

Altoona Center for Clinical Research, Duncansville

21224

Johns Hopkins Bayview Medical Center, Baltimore

28025

NorthEast Rheumatology, Concord

87106

New Mexico Clinical Research & Osteoporosis Center, Albuquerque

0112

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Tbilisi

050159

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician, Bucharest